## **Core Concept**
The question revolves around the prevention of congenital adrenal hyperplasia (CAH) in a fetus whose sibling has been diagnosed with the condition. CAH is a group of inherited disorders that affect the adrenal glands, most commonly caused by 21-hydroxylase deficiency. This deficiency leads to impaired cortisol and aldosterone production and an overproduction of androgens.

## **Why the Correct Answer is Right**
The correct answer, **Dexamethasone**, is given to prevent the virilization of a female fetus affected by congenital adrenal hyperplasia. Dexamethasone is a synthetic glucocorticoid that crosses the placenta and can suppress fetal adrenal androgen production, thereby preventing virilization of a female fetus with CAH. The treatment is specifically considered when there is a history of CAH in a sibling and when the genotype of the parents suggests a high risk of CAH in the fetus.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while **Prednisolone** is a glucocorticoid, it does not cross the placenta as effectively as dexamethasone.
- **Option B:** This option is incorrect as there is no standard drug listed here which is used for preventing CAH.
- **Option C:** This option is incorrect as there is no standard drug listed here which is used for preventing CAH.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that this treatment approach requires careful consideration, including confirmation of the pregnancy, assessment of the risk to the fetus, and ideally, genetic testing to determine if the fetus is affected. The use of dexamethasone in this context is a preventive measure specifically aimed at reducing the impact of CAH on a female fetus.

## **Correct Answer:** **D. Dexamethasone**